Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder

International Journal of Neuropsychopharmacology

Volumn 12, Issue 1, 2009, Pages 33-43

  Hayashi, Akiko ^a   Kasahara, Takaoki ^a   Kametani, Mizue ^a   Toyota, Tomoko ^a   Yoshikawa, Takeo ^a   Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Bipolar disorder; Calcium homeostasis; Endoplasmic reticulum stress; GRP94; Lymphoblastoid cells; XBP1

Indexed keywords

CALRETICULIN; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MESSENGER RNA; THAPSIGARGIN; TUNICAMYCIN; X BOX BINDING PROTEIN 1; ENZYME INHIBITOR; GLUCOSE REGULATED PROTEINS; GLUCOSE-REGULATED PROTEINS; HEAT SHOCK PROTEIN 70; MEMBRANE PROTEIN; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FEMALE; HAPLOTYPE; HUMAN; LYMPHOBLASTOID CELL; MAJOR CLINICAL STUDY; MALE; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; STRESS; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; LYMPHOCYTE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PROTEIN FOLDING; PSYCHOLOGICAL RATING SCALE;

ADULT; BIPOLAR DISORDER; CELLS, CULTURED; ENDOPLASMIC RETICULUM; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LYMPHOCYTES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROTEIN FOLDING; PSYCHIATRIC STATUS RATING SCALES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STRESS, PHYSIOLOGICAL; THAPSIGARGIN; TUNICAMYCIN;

EID: 61949186636     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708009358     Document Type: Article

References (48)

1. Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht BD (2007). XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Molecular Cell 27, 53-66.
2. Altshuler LL, Curran JG, Hauser P, Mintz J, Denicoff K, Post R (1995). T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. American Journal of Psychiatry 152, 1139-1144.
3. Chen B, Wang JF, Young LT (2000). Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus. Biological Psychiatry 48, 658-664.
4. Chen G, Huang LD, Jiang YM, Manji HK (1999a). The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. Journal of Neurochemistry 72, 1327-1330.
5. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK (1999b). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. Journal of Neurochemistry 72, 879-882.
6. Chuang DM (2005). The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Annals of the New York Academy of Sciences 1053, 195-204.
7. Cichon S, Buervenich S, Kirov G, Akula N, Dimitrova A, Green E, Schumacher J, Klopp N, Becker T, Ohlraun S, et al. (2004). Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin. Nature Genetics 36, 783-784; author reply 784-785.
8. Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Gonçalves CA, Santin A, Kapczinski F (2006). Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neuroscience Letters 398, 215-219.
9. Donati G, Imbriano C, Mantovani R (2006). Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters. Nucleic Acids Research 34, 3116-3127.
10. Dow GS, Hudson TH, Vahey M, Koenig ML (2003). The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro. Malaria Journal 2, 14.
11. Fonseca SG, Fukuma M, Lipson KL, Nguyen LX, Allen JR, Oka Y, Urano F (2005). WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells. Journal of Biological Chemistry 280, 39609-39615.
12. Goodwin FK, Jamison KR (2007). Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd edn. New York: Oxford University Press.
13. Hayashi A, Kasahara T, Iwamoto K, Ishiwata M, Kametani M, Kakiuchi C, Furuichi T, Kato T (2007). The Role of brain-derived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development. Journal of Biological Chemistry 282, 34525-34534.
14. Hou SJ, Yen FC, Cheng CY, Tsai SJ, Hong CJ (2004). X-box binding protein 1 (XBP1) C-116G polymorphisms in bipolar disorders and age of onset. Neuroscience Letters 367, 232-234.
15. Kakiuchi C, Ishiwata M, Hayashi A, Kato T (2006). XBP1 induces WFS1 through an endoplasmic reticulum stress response element-like motif in SH-SY5Y cells. Journal of Neurochemistry 97, 545-555.
16. Kakiuchi C, Ishiwata M, Nanko S, Kunugi H, Minabe Y, Nakamura K, Mori N, Fujii K, Umekage T, Tochigi M, et al. (2005). Functional polymorphisms of HSPA5: possible association with bipolar disorder. Biochemical and Biophysical Research Communications 336, 1136-1143.
17. Kakiuchi C, Ishiwata M, Nanko S, Kunugi H, Minabe Y, Nakamura K, Mori N, Fujii K, Umekage T, Tochigi M, et al. (2007). Association analysis of HSP90B1 with bipolar disorder. Journal of Human Genetics 52, 794-803.
18. Kakiuchi C, Iwamoto K, Ishiwata M, Bundo M, Kasahara T, Kusumi I, Tsujita T, Okazaki Y, Nanko S, Kunugi H, et al. (2003). Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nature Genetics 35, 171-175.
19. Kato T (2007). Molecular genetics of bipolar disorder and depression. Psychiatry and Clinical Neurosciences 61, 1-17.
20. Kato T (2008). Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder. Cell Calcium 44, 92-102.
21. 2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder. International Journal of Neuropsychopharmacology 6, 379-389.
22. Lee K, Tirasophon W, Shen X, Michalak M, Prywes R, Okada T, Yoshida H, Mori K, Kaufman RJ (2002). IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Development 16, 452-466.
23. Manji HK, Duman RS (2001). Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacology Bulletin 35, 5-49.
24. McCurdy RD, Feron F, Perry C, Chant DC, McLean D, Matigian N, Hayward NK, McGrath JJ, Mackay-Sim A (2006). Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophrenia Research 82, 163-173.
25. 2+ store: a view from the lumen. Trends in Biochemical Sciences 23, 10-14.
26. Murakami T, Hino SI, Saito A, Imaizumi K (2007). Endoplasmic reticulum stress response in dendrites of cultured primary neurons. Neuroscience 146, 1-8.
27. Shaltiel G, Chen G, Manji HK (2007). Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Current Opinion in Pharmacology 7, 22-26.
28. Shao L, Sun X, Xu L, Young LT, Wang JF (2006). Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sciences 78, 1317-1323.
29. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 (Suppl. 20), 22-33, quiz 34-57.
30. Shim J, Umemura T, Nothstein E, Rongo C (2004). The unfolded protein response regulates glutamate receptor export from the endoplasmic reticulum. Molecular Biology of the Cell 15, 4818-4828.
31. So J, Warsh JJ, Li PP (2007). Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder. Biological Psychiatry 62, 141-147.
32. Stork C, Renshaw PF (2005). Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry 10, 900-919.
33. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, et al. (2007). Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848-853.
34. Swift M, Swift RG (2000). Psychiatric disorders and mutations at the Wolfram syndrome locus. Biological Psychiatry 47, 787-793.
35. Tate CG, Whiteley E, Betenbaugh MJ (1999). Molecular chaperones stimulate the functional expression of the cocaine-sensitive serotonin transporter. Journal of Biological Chemistry 274, 17551-17558.
36. Toda H, Suzuki G, Nibuya M, Shioda K, Nishijima K, Wakizono T, Kanda Y, Watanabe Y, Shimizu K, Nomura S (2006). Behavioral stress and activated serotonergic neurotransmission induce XBP-1 splicing in the rat brain. Brain Research 1112, 26-32.
37. Tordai A, Brass LF, Gelfand EW (1995). Tunicamycin inhibits the expression of functional thrombin receptors on human T-lymphoblastoid cells. Biochemical and Biophysical Research Communications 206, 857-862.
38. 2+)-ATPases. Trends in Pharmacological Sciences 19, 131-135.
39. Videbech P (1997). MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatrica Scandinavica 96, 157-168.
40. Warsh JJ, Andreopoulos S, Li PP (2004). Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: current status. Clinical Neuroscience Research 4, 201-213.
41. Wellcome Trust Case Control Consortium (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.
42. Williams RS, Cheng L, Mudge AW, Harwood AJ (2002). A common mechanism of action for three mood-stabilizing drugs. Nature 417, 292-295.
43. Yamamoto K, Yoshida H, Kokame K, Kaufman RJ, Mori K (2004). Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. Journal of Biochemistry (Tokyo) 136, 343-350.
44. Yoshida H (2007). Unconventional splicing of XBP-1 mRNA in the unfolded protein response. Antioxidants & Redox Signaling 9, 2323-2333.
45. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K (2001). XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881-891.
46. Yoshida H, Okada T, Haze K, Yanagi H, Yura T, Negishi M, Mori K (2000). ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Molecular and Cellular Biology 20, 6755-6767.
47. Yu Z, Luo H, Fu W, Mattson MP (1999). The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Experimental Neurology 155, 302-314.
48. Yuan PX, Huang LD, Jiang YM, Gutkind JS, Manji HK, Chen G (2001). The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. Journal of Biological Chemistry 276, 31674-31683.